A novel artificial intelligence and biosensor device has been developed to monitor if live cancer cells remain after chemotherapy treatment.
Researchers from the University of Strathclyde (Glasgow, UK) have developed a new biomarker test that could diagnose sepsis in under 3 minutes.
Researchers fromat the University of British Columbia Okanagan (Kelowna, Canada) have developed a tool, using biosensors, to provide almost instant diagnosis of bacterial infections.
Researchers have developed a new nanoplasmonic biosensor device that precisely detects the presence of anticoagulants in blood samples.
Find out more about a novel biosensor for the real time oxygen monitoring for organ-on-a-chip systems, and a liquid biopsy for predicting lymphoma therapy success.
Read more about the top stories in new technology developments in this week’s news round-up.
A collaboration of researchers from KAUST (Thuwal, Saudi Arabia), Imperial College London (London, UK) and the University of Cambridge (Cambridge, UK), have recently developed a novel concept for a biosensor of the metabolite, lactate.
Read time: 2 mins
In this week’s news round-up, find out more about a T cell biomarker for the prediction of advanced chronic lymphocytic leukemia patients response to CAR T therapy, and about a wearable biosensor for measuring biomarkers in sweat.
In this methodology, the authors present a label-free platform for dopamine (DA) monitoring based on the spectroscopic properties of laccase. The method permits the determination of DA and the total concentration of the three neurotransmitters, and could be used for DA monitoring in urine samples.
In this editorial, the author discusses paper-based assays as an emerging technology in bioanalysis, as well as point-of care diagnostics and treatment.